Effect of synbiotics in infants with atopic dermatitis up to 7 years of life

Effect of synbiotics in infants with atopic dermatitis up to 7 years of life - SYNBAD Follow Up Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34194

Enrollment

Registered

2010-12-21

Start date

2011-03-24

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma and allergies

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: - Participation to and completion of the Synbad study - Between 5 years and 6 months and 6 years of age - Written informed consent from parents/caregivers/legal representatives

Exclusion criteria

Exclusion criteria: Investigator's uncertainty about the willingness or ability of the family to comply with the protocol requirements

Design outcomes

Primary

Measure	Time frame
The primary study parameter of this study is the physician*s diagnosed asthma and controllability (GINA classification) at the age up to 7 years.	—

Secondary

Measure	Time frame
- Allergic manifestations: diagnosed by physician or by means of questionnaires (ISAAC derived), including severity (if available) - Blood analysis (Ig's, cytokines) - Fecal parameters (bacterial content, PH) - Anthropometry - Molecular pattern recognition by smell prints of exhaled volatile organic compounds (Electronic Nose®)	—

Countries

Netherlands

Outcome results